A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People

Summary

The study is testing a new study medicine, which is being tested as a potential medicine to treat cardiometabolic diseases. The aim of this study is to see if the study medicine is safe, how it works in participants body, and what the body does to the study medicine. Participants will either get NNC6022-0001 (the new study medicine) or placebo (a "dummy medicine" without the active ingredient). Which treatment participants get is decided by chance. The study medicine is a potential new medicine which cannot be prescribed by doctors. The study will last for about 10 months in total.

Timeline

Start

2024-03-28

Primary completion

2025-02-10

Completion

2025-02-17

Drugs

Indications